Trial NCT02289222

View at ClinicalTrials.gov 
Org. Study IDs: HP-00061522; GCC1454

Last trial update was posted on 2019-11-05

MeSH Interventions

Dexamethasone Pembrolizumab Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Due to the inclusion of an IMid in combination with pembrolizumab, Study Sponsor terminated the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID